Blandt atten patienter, som ikke tålte eller havde infektioner refraktære over for amphotericin B eller itraconazol, blev syv patienter klassificeret som responders.
Among eighteen patients who were intolerant or had infections refractory to amphotericin B or itraconazole, seven patients were classed as responders.